πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 8 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12156862

Medicaments for the treatment of vasoconstriction related diseases or disorders

Sulfateq B.V. Β· Granted Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11730741

6-chromanol derivatives for use as a medicament

Sulfateq B.V. Β· Granted Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11006626

Compounds for protection of cells

Sulfateq B.V. Β· Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10676452

Compound for the prophylaxis or treatment of organ damage

Sulfateq B.V. Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10426771

6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive ai

Sulfateq B.V. Β· Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10322124

6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive ai

Sulfateq B.V. Β· Granted Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10123529

Compounds for protection of cells

Sulfateq B.V. Β· Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9913841

6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive ai

Sulfateq B.V. Β· Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted